CABOT ($CBT) posted quarterly earnings results for Q2 2026 on Tuesday, May 5th. The company reported earnings of $1.61 per share, beating estimates of $1.47 by $0.14. The company also reported revenue of $904,000,000, missing estimates of $909,308,050 by $-5,308,050.
You can see Quiver Quantitative's $CBT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CABOT Hedge Fund Activity
We have seen 175 institutional investors add shares of CABOT stock to their portfolio, and 201 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 744,717 shares (+337.5%) to their portfolio in Q4 2025, for an estimated $49,359,842
- COPELAND CAPITAL MANAGEMENT, LLC removed 524,278 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $34,749,145
- WELLINGTON MANAGEMENT GROUP LLP removed 423,471 shares (-10.1%) from their portfolio in Q4 2025, for an estimated $28,067,657
- PROSHARE ADVISORS LLC added 349,861 shares (+2125.5%) to their portfolio in Q1 2026, for an estimated $26,348,031
- UBS GROUP AG removed 326,725 shares (-53.2%) from their portfolio in Q1 2026, for an estimated $24,605,659
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 319,517 shares (-59.4%) from their portfolio in Q4 2025, for an estimated $21,177,586
- LIGHTROCK NETHERLANDS B.V. added 317,934 shares (+227.3%) to their portfolio in Q4 2025, for an estimated $21,072,665
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
CABOT Analyst Ratings
Wall Street analysts have issued reports on $CBT in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 11/28/2025
To track analyst ratings and price targets for CABOT, check out Quiver Quantitative's $CBT forecast page.
CABOT Price Targets
Multiple analysts have issued price targets for $CBT recently. We have seen 3 analysts offer price targets for $CBT in the last 6 months, with a median target of $75.0.
Here are some recent targets:
- John Roberts from Mizuho set a target price of $75.0 on 02/05/2026
- Joshua Spector from UBS set a target price of $81.0 on 02/05/2026
- Jeffrey Zekauskas from JP Morgan set a target price of $54.0 on 11/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
